The principle task of Immunovia´s Investor Relations is to provide investors and the capital market with accurate, relevant and timely information that facilitates an understanding of the operations of Immunova AB.
Contact Investor Relations for details:
Mats Grahn, CEO
Mobile: +46 70 5320230
You are also welcome to ask your question or make your request by: